1. Home
  2. MIST vs FOSL Comparison

MIST vs FOSL Comparison

Compare MIST & FOSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIST
  • FOSL
  • Stock Information
  • Founded
  • MIST 2003
  • FOSL 1984
  • Country
  • MIST Canada
  • FOSL United States
  • Employees
  • MIST N/A
  • FOSL N/A
  • Industry
  • MIST Biotechnology: Pharmaceutical Preparations
  • FOSL Consumer Specialties
  • Sector
  • MIST Health Care
  • FOSL Consumer Discretionary
  • Exchange
  • MIST Nasdaq
  • FOSL Nasdaq
  • Market Cap
  • MIST 81.5M
  • FOSL 55.3M
  • IPO Year
  • MIST N/A
  • FOSL 1993
  • Fundamental
  • Price
  • MIST $1.43
  • FOSL $1.24
  • Analyst Decision
  • MIST Strong Buy
  • FOSL
  • Analyst Count
  • MIST 3
  • FOSL 0
  • Target Price
  • MIST $13.00
  • FOSL N/A
  • AVG Volume (30 Days)
  • MIST 177.8K
  • FOSL 196.4K
  • Earning Date
  • MIST 11-11-2024
  • FOSL 11-07-2024
  • Dividend Yield
  • MIST N/A
  • FOSL N/A
  • EPS Growth
  • MIST N/A
  • FOSL N/A
  • EPS
  • MIST N/A
  • FOSL N/A
  • Revenue
  • MIST N/A
  • FOSL $1,280,256,000.00
  • Revenue This Year
  • MIST N/A
  • FOSL N/A
  • Revenue Next Year
  • MIST N/A
  • FOSL N/A
  • P/E Ratio
  • MIST N/A
  • FOSL N/A
  • Revenue Growth
  • MIST N/A
  • FOSL N/A
  • 52 Week Low
  • MIST $1.12
  • FOSL $0.75
  • 52 Week High
  • MIST $3.52
  • FOSL $1.83
  • Technical
  • Relative Strength Index (RSI)
  • MIST 42.50
  • FOSL 50.18
  • Support Level
  • MIST $1.41
  • FOSL $1.13
  • Resistance Level
  • MIST $1.53
  • FOSL $1.19
  • Average True Range (ATR)
  • MIST 0.07
  • FOSL 0.05
  • MACD
  • MIST -0.01
  • FOSL -0.01
  • Stochastic Oscillator
  • MIST 26.96
  • FOSL 40.00

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

About FOSL Fossil Group Inc.

Fossil Group Inc is a design, innovation and distribution company in consumer fashion accessories. The products include traditional watches, smartwatches, jewelry, handbags, small leather goods, belts and sunglasses. The reportable segments are comprised of 1) Americas segment includes sales in Canada, Latin America and the United States. 2) Europe segment includes sales in European countries, the Middle East and Africa. 3) Asia segment includes sales in Australia, China, India, Indonesia, Japan, Malaysia, New Zealand, Singapore, South Korea and Thailand. Each reportable operating segment includes sales to wholesale and distributor customers, and sales through Company-owned retail stores and e-commerce activities based on the location of the selling entity.

Share on Social Networks: